Kineticos Life Sciences supports Biopharmaceutical and Precision Medicine firms from concept to commercialization. Kineticos launched in 2007 offering strategy, licensing, and market access consulting support for Precision Medicine. In 2012, they added portfolio strategy, business development, and commercial support. In 2020, Kineticos launched the Disruptor Fund, offering start-ups integrated intelligent funding, biotech expertise, and thoughtful execution. Kineticos remains committed to advancing the boundaries of scientific research and improving patient care.